| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.11. | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | 1 | RTTNews | ||
| 09.11. | LifeStance prices $590.4M secondary offering at $13.12 per share | 1 | Seeking Alpha | ||
| 09.11. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 09.11. | LifeStance announces 45M share secondary offering and 2M share repurchase | 2 | Seeking Alpha | ||
| 09.11. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 06.11. | BMO raises Lifestance Health stock price target on strong results | 5 | Investing.com | ||
| 04.11. | LifeStance Health Group Q3 2026 Earnings Preview | 5 | Seeking Alpha | ||
| 16.10. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.10. | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| 05.10. | KeyBanc raises Lifestance Health stock price target on specialty care growth | 2 | Investing.com | ||
| 15.09. | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | 1 | Investing.com Deutsch | ||
| 11.09. | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.09. | LifeStance prices 22.3 million share secondary offering at $12.35 | 2 | Investing.com | ||
| 09.09. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Pricing of Secondary Public Offering | 4 | GlobeNewswire (USA) | ||
| 09.09. | Canaccord raises Lifestance Health stock price target on growth outlook | 1 | Investing.com | ||
| 09.09. | LifeStance stockholders plan to sell 22.3 million shares | 1 | Investing.com | ||
| 10.08. | LifeStance Health gains as Hedgeye adds as new long idea | 1 | Seeking Alpha | ||
| 06.08. | LifeStance Q2 2026 slides: 94% EBITDA surge, raised outlook | 9 | Investing.com | ||
| 06.08. | LifeStance Q2 2026 slides: profitability surges as margins expand | 1 | Investing.com | ||
| 06.08. | LifeStance Health Group beats top-line and bottom-line estimates; raises FY26 outlook | 2 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 51,38 | -0,77 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach Zahlen zum dritten Quartal von 58 auf 65 Euro angehoben und die Einstufung auf "Kaufen" belassen. Die Partnerschaft... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,600 | +2,40 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,960 | -1,96 % | Siemens Healthineers Aktie: Zwischen Übergangsjahr und Kursfantasie | Die Analysten sind sich nach den jüngsten Quartalszahlen von Siemens Healthineers uneinig über die weiteren Perspektiven der Aktie. Während Jefferies nach der Erholung im Geschäft mit medizinischer... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,900 | -1,12 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 27 auf 26 Euro gekappt und die Aktien von "Equal Weight" auf "Underweight" abgestuft. Dem... ► Artikel lesen | |
| TELADOC HEALTH | 6,860 | +0,91 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| EUROFINS SCIENTIFIC | 84,20 | +0,19 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 09th November to 13th November 2026 |
Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 38,350 | +0,12 % | Boston Scientific Corporation: Boston Scientific announces pricing of $3.0 billion and €4.25 billion offerings of senior notes | MARLBOROUGH, Mass., Nov. 19, 2026 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) announced today that it has priced a public offering of $3,000,000,000 aggregate principal... ► Artikel lesen | |
| DEXCOM | 72,00 | -0,55 % | DexCom, Inc.: Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone | Opening ceremony attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Minister for Enterprise, Tourism and Employment, Peter... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 145,00 | +2,40 % | Align Technology beruft zwei neue Mitglieder in den Verwaltungsrat | ||
| INMODE | 11,335 | +0,04 % | InMode Ltd.: InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook | YOKNEAM, Israel, Nov. 11, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| PETMED EXPRESS | 0,783 | +0,13 % | PetMed Express: Verlust steigt - kann der Plan noch greifen? | ||
| TANDEM DIABETES | 16,100 | +0,62 % | Warum die Aktie von Tandem Diabetes Care heute kräftig zulegt | ||
| INSULET | 122,00 | +0,37 % | Insulet downgraded at Baird on concerns over insulin pump loyalty | ||
| ORGANON | 12,640 | -0,28 % | Sun Pharma plant 4-Milliarden-Dollar-Kredit zur Refinanzierung der Organon-Übernahme | ||
| MOLINA HEALTHCARE | 182,00 | +0,52 % | Molina Healthcare Commits $2.4 Million To Illinois Community Care Programs |